John Marsden

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Venues

Addiction (Abingdon, England)

BMJ open

Trials

PLoS medicine

King's College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London

United Kingdom

Professor of Addiction Psychology :: Addictions Department, Institute of Psychiatry, Psychology & Neuroscience

Publications

Christina M Andrews, Wayne Denis Hall, Keith N Humphreys, John Marsden
Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis? Addiction (Abingdon, England) (2024)
Gemma Scott, Sophie Turner, Natalie Lowry, Annette Hodge, Waniya Ashraf, Katie McClean, Mike Kelleher, Luke Mitcheson, John Marsden
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study. BMJ open 13 (3) (2023)
Keith N Humphreys, Rob Calder, John Marsden, Edward Day
How Addiction handles disagreements over potentially harmful terminology. Addiction (Abingdon, England) (2023)
Gemma Scott, Sophie Turner, Natalie Lowry, Annette Hodge, Waniya Ashraf, Katie McClean, Mike Kelleher, Luke Mitcheson, John Marsden
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study. BMJ open 13 (3) (2023)
Gemma Scott, Sophie Turner, Natalie Lowry, Annette Hodge, Waniya Ashraf, Katie McClean, Mike Kelleher, Luke Mitcheson, John Marsden
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study. BMJ open 13 (3) (2023)
Kim Donoghue, Sadie Boniface, Eileen Brobbin, Sarah Byford, Rachel Coleman, Simon Coulton, Edward Day, Ranjita Dhital, Anum Farid, Laura Hermann, Amy Louise Jordan, Andreas Kimergård, Maria-Leoni Koutsou, Anne Lingford-Hughes, John Marsden, Joanne Neale, Aimee O'Neill, Thomas Phillips, James Shearer, Julia M A Sinclair, Joanna Smith, Sir John Strang, John Weinman, Cate Whittlesea, Kideshini Widyaratna, Colin Drummond
Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT. Health technology assessment (Winchester, England) 27 (22) (2023)
John Marsden, Jamie Brown, Luke Clark, Janna Cousijn, Wayne Denis Hall, Matthew Hickman, John Holmes, Keith N Humphreys, Sarah E Jackson, Amy Peacock, Jalie A Tucker
The impact of the COVID-19 pandemic on addictive disorders-an update. Addiction (Abingdon, England) 117 (11) (2022)
Natalie Lowry, Fiona Cowden, Edward Day, Eilish Gilvarry, Stacey Johnstone, Robbie Murray, Mike Kelleher, Luke Mitcheson, John Marsden
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation. BMJ open 12 (10) (2022)
John Marsden, Mike Kelleher, Zoë Hoare, Dyfrig Hughes, Jatinder Bisla, Angela Cape, Fiona Cowden, Edward Day, Jonathan Dewhurst, Rachel Evans, Andrea Hearn, Joanna Kelly, Natalie Lowry, Martin McCusker, Caroline Murphy, Robert Murray, Tracey Myton, Sophie Quarshie, Gemma Scott, Sophie Turner, Rob Vanderwaal, April Wareham, Eilish Gilvarry, Luke Mitcheson
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone. Trials 23 (1) (2022)
Niranjan S Karnik, John Marsden, Connor McCluskey, Randy A Boley, Katharine A Bradley, Cynthia I Campbell, Megan E Curtis, David A Fiellin, Udi Ghitza, Kathryn Hefner, Yih-Ing Hser, R Kathryn McHugh, Sterling Marshall McPherson, Larissa J Mooney, Landhing M Moran, Sean M Murphy, Robert P Schwartz, Dikla Shmueli-Blumberg, Matisyahu Shulman, Kari A Stephens, Katherine E Watkins, Roger D Weiss, Li-Tzy Wu
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction (Abingdon, England) 117 (9) (2022)
Keith N Humphreys, John Marsden
Responding to 100 000 annual drug overdose deaths in the United States: a special section of commentaries. Addiction (Abingdon, England) 117 (5) (2022)
John Marsden, Janna Cousijn, John Stapleton
Pre-registration: not a daunting practice. Addiction (Abingdon, England) 117 (4) (2022)
John Marsden
Addiction is moving online-only in 2023. Addiction (Abingdon, England) 117 (11) (2022)
Keith N Humphreys, John Marsden
Synthesizing advice to the United States from other nations that have experienced drug epidemics. Addiction (Abingdon, England) 117 (5) (2022)
Matthew Hickman, Janna Cousijn, John Marsden, Lindsey A Hines, Edward Day
Promoting addiction science after Brexit-what can Addiction and SSA do and what does UK government need to do? Addiction (Abingdon, England) 116 (10) (2021)
Natalie Lowry, John Marsden, Bethany Clydesdale, Brian Eastwood, Eva Maria Havelka, Camille Goetz
Acute impact of self-guided mental imagery on craving in cocaine use disorder: a mixed-methods analysis of a randomized controlled trial. Addiction (Abingdon, England) 116 (9) (2021)
John Marsden
A message from Addiction's new Editor-in-Chief, Professor John Marsden. Addiction (Abingdon, England) 116 (1) (2021)
Hesham Farouk Elarabi, Mansour Shawky, Nael Mustafa, Doaa Radwan, Abuelgasim Elarasheed, Ahmed Yousif Ali, Mona Osman, Ahmed Kashmar, Helal Al Kathiri, Tarek Gawad, Ayman Kodera, Mohammed Al Jneibi, Abdu Adem, Amanda J Lee, John Marsden
Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial. Addiction (Abingdon, England) 116 (9) (2021)
Harry Tattan-Birch, John Marsden, Robert J West, Suzanne H Gage
Assessing and addressing collider bias in addiction research: the curious case of smoking and COVID-19. Addiction (Abingdon, England) 116 (5) (2021)
John Marsden, Paul Anders, Helen Clark, Kyriacos Colocassis, Brian Eastwood, Jonathan Knight, Alexandra Melaugh, David Quinn, Virginia Wright, Jez Stannard
Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence. Trials 21 (1) (2020)
John Marsden, Shane Darke, Wayne Denis Hall, Matthew Hickman, John Holmes, Keith N Humphreys, Joanne Neale, Jalie A Tucker, Robert West
Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction (Abingdon, England) 115 (6) (2020)
John Marsden, Betty Tai, Robert Ali, Lian Hu, Agustus John Rush, Nora D Volkow
Response to commentaries. Addiction (Abingdon, England) 114 (8) (2020)
Robert West, John Marsden, Janna Hastings
Addiction Theories and Constructs: a new series. Addiction (Abingdon, England) 114 (6) (2019)
John Marsden, Betty Tai, Robert Ali, Lian Hu, A John Rush, Nora Volkow
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective? Addiction (Abingdon, England) 114 (8) (2019)
John A A MacLeod, Colin Steer, Kate Tilling, Rosie Cornish, John Marsden, Tim Millar, Sir John Strang, Matthew Hickman
Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS medicine 16 (11) (2019)
Emma Beard, John Marsden, Jamie Brown, Ildiko Tombor, John Stapleton, Susan Michie, Robert J West
Understanding and using time series analyses in addiction research. Addiction (Abingdon, England) 114 (10) (2019)
Matthew Hickman, Colin Steer, Kate Tilling, Aaron G Lim, John Marsden, Tim Millar, Sir John Strang, Maggie Telfer, Peter Vickerman, John Macleod
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction (Abingdon, England) 113 (8) (2018)
Amy Peacock, Janni K Y Leung, Sarah Larney, Samantha Colledge, Matthew Hickman, Jürgen Rehm, Gary A Giovino, Robert West, Wayne Denis Hall, Paul Griffiths, Robert L Ali, Linda R Gowing, John Marsden, Alize J Ferrari, Jason Grebely, Michael Farrell, Louisa Degenhardt
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction (Abingdon, England) 113 (10) (2018)
Wayne Denis Hall, Robert West, John Marsden, Keith N Humphreys, Joanne Neale, Nancy M Petry
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. Addiction (Abingdon, England) 113 (6) (2018)
Wayne Denis Hall, Robert J West, John Marsden, Keith N Humphreys, Joanne Neale, Nancy M Petry
The need for more consistent evidential standards in cannabis policy evaluations. Addiction (Abingdon, England) 113 (8) (2018)
John Marsden, Garry Stillwell, Hayley Jones, Alisha Cooper, Brian Eastwood, Michael Farrell, Tim Lowden, Nino Maddalena, Chris Metcalfe, Jenny Shaw, Matthew Hickman
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction (Abingdon, England) 112 (8) (2017)

John Marsden.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

John Marsden